Goldraij A, Gimeno M A, Sterin A B, Gimeno A L
Facultad de Odontología, Universidad Nacional de Córdoba, Buenos Aires, Argentina.
Methods Find Exp Clin Pharmacol. 1987 Oct;9(10):643-8.
The in vitro spontaneous isometric-developed tension (IDT) of uterine horns obtained from diestrous rats exhibited, after 60 min of post-isolation activity, a clear decrease in magnitude, averaging 18.2 +/- 5.2%. In presence of tolbutamide, a concentration-dependent decrease of IDT, significantly greater than the spontaneous reduction (75.1 +/- 5.4%, with tolbutamide at 10(-4) M), was observed. Incubation with propranolol (10(-6) M) or with sotalol (10(-4) M) failed to alter the negative inotropism evoked by tolbutamide. On the other hand, the sulfonylurea (10(-4) M) shifted most points of the dose-response curve to the right for the contractile stimulation elicited by oxytocin, an influence not altered by the simultaneous presence of propranolol or sotalol. Tolbutamide failed to influence the negative inotropic dose-response curve for isoproterenol and did not modify the decrease in contractions evoked by theophylline (10(-4) M). It was also found that tolbutamide was devoid of action on the basal release of prostaglandin E2 from uterine strips and on the positive inotropic dose-response curve for added PGE2 or PGF2 alpha, constructed in presence of indomethacin (5 X 10(-6) M). The present findings do not permit a simple explanation regarding possible factors underlying the negative uterine inotropic influence of tolbutamide in the rat uterus. However, it appears that alterations in the integrity of tissue excitability and contractile apparatus, adrenergic implications, changes in uterine cAMP levels, inhibition of cyclo-oxygenase or low PEG2 synthesis and release, are not plausible mechanisms to explain the negative inotropism of tolbutamide. Therefore, it is suggested that the contractile depression evoked by tolbutamide and its action on the contractile effect of oxytocin might be linked to the impaired synthesis of other prostanoids, namely PGF2 alpha, PGI2 or PGD2, although the participation of not yet determined factor(s), namely changes in Ca2+ ion movements, cannot be discarded.
从处于动情后期的大鼠获得的子宫角的体外自发等长收缩张力(IDT),在分离后活动60分钟后,幅度明显下降,平均下降18.2±5.2%。在存在甲苯磺丁脲的情况下,观察到IDT呈浓度依赖性下降,显著大于自发下降(在10⁻⁴M甲苯磺丁脲时为75.1±5.4%)。用普萘洛尔(10⁻⁶M)或索他洛尔(10⁻⁴M)孵育未能改变甲苯磺丁脲引起的负性肌力作用。另一方面,磺脲类药物(10⁻⁴M)使催产素引起的收缩刺激的剂量反应曲线的大多数点向右移动,这种影响不受普萘洛尔或索他洛尔同时存在的影响。甲苯磺丁脲未能影响异丙肾上腺素的负性肌力剂量反应曲线,也未改变茶碱(10⁻⁴M)引起的收缩下降。还发现甲苯磺丁脲对子宫条带中前列腺素E2的基础释放以及在吲哚美辛(5×10⁻⁶M)存在下构建的添加PGE2或PGF2α的正性肌力剂量反应曲线没有作用。目前的研究结果无法对甲苯磺丁脲对大鼠子宫负性肌力作用的潜在因素作出简单解释。然而,组织兴奋性和收缩装置完整性的改变、肾上腺素能影响、子宫cAMP水平的变化、环氧化酶的抑制或低PEG2合成与释放,似乎都不是解释甲苯磺丁脲负性肌力作用的合理机制。因此,有人提出,甲苯磺丁脲引起的收缩抑制及其对催产素收缩作用的影响可能与其他前列腺素(即PGF2α、PGI2或PGD2)合成受损有关,尽管尚未确定的因素(即Ca²⁺离子运动的变化)的参与也不能排除。